Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors

Clinical Microbiology and Infection

Volumn 20, Issue 8, 2014, Pages

  Titelman, E ^a   Hasan, C M ^a   Iversen, A ^a   Naucler P ^a   Kais, M ^a   Kalin, M ^a   Giske, C G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CTX M 15; Extended spectrum lactamase; Phylogroup B2; ST131; Stool colonization

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE CTX M; EXTENDED SPECTRUM BETA LACTAMASE; BACTERIAL DNA; BETA LACTAMASE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATION; CLONE; DISEASE ASSOCIATION; ENTEROBACTERIACEAE INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FECES ANALYSIS; FEMALE; GENOTYPE; HOST; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYLOGENY; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; QUESTIONNAIRE; REPLICON; RISK FACTOR; CLASSIFICATION; COHORT ANALYSIS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; FECES; GENETICS; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; PROSPECTIVE STUDY; SECRETION (PROCESS); TIME;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARRIER STATE; COHORT STUDIES; DNA, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; PROSPECTIVE STUDIES; QUESTIONNAIRES; TIME FACTORS;

EID: 84906789757     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12559     Document Type: Article

References (30)

1. Oteo J, Perez-Vazquez M, Campos J. Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010; 23: 320-326.
2. Pitout JD. Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol 2012; 3: 9.
3. Hilty M, Betsch BY, Bogli-Stuber K et al. Transmission dynamics of extended-spectrum β -lactamase-producing enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis 2005; 55: 967-975.
4. Apisarnthanarak A, Bailey TC, Fraser VJ. Duration of stool colonization in patients infected with extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2008; 46: 1322-1323.
5. Warren RE, Harvey G, Carr R, Ward D, Doroshenko A. Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community. Clin Microbiol Infect 2008; 14 (suppl 1): 124-133.
6. Feldman N, Adler A, Molshatzki N et al. Gastrointestinal colonization by kpc-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin Microbiol Infect 2013; 19: E190-196.
7. Wold AE, Caugant DA, Lidin-Janson G, de Man P, Svanborg C. Resident colonic Escherichia coli strains frequently display uropathogenic characteristics. J Infect Dis 1992; 165: 46-52.
8. Ostblom A, Adlerberth I, Wold AE, Nowrouzian FL. Pathogenicity island markers, virulence determinants malx and usp, and the capacity of Escherichia coli to persist in infants' commensal microbiotas. Appl Environ Microbiol 2011; 77: 2303-2308.
9. Melican K, Sandoval RM, Kader A et al. Uropathogenic Escherichia coli p and type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction. PLoS Pathog 2011; 7: e1001298.
10. Coque TM, Novais A, Carattoli A et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008; 14: 195-200.
11. Novais A, Canton R, Moreira R, Peixe L, Baquero F, Coque TM. Emergence and dissemination of enterobacteriaceae isolates producing CTX-M-1-like enzymes in Spain are associated with incfii (CTX-M-15) and broad-host-range (CTX-M-1, -3, and -32) plasmids. Antimicrob Agents Chemother 2007; 51: 796-799.
12. Carattoli A. Plasmids and the spread of resistance. Int J Med Microbiol 2013; 303: 298-304.
13. Titelman E, Iversen A, Kais M, Kalin M, Giske CG. Efficacy of pivmecillinam for lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist 2012; 18: 189-192.
14. SWEDRES. A report on Swedish antibicrobial utilisation and resistance in human medicine. Swedish Institute for Communicable Disease Control. 2009. http://www.folkhalsomyndigheten.se/pagefiles/12891/swedres-2009.pdf.
15. Birkett CI, Ludlam HA, Woodford N et al. Real-time taqman PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum β-lactamases. J Med Microbiol 2007; 56: 52-55.
16. Cohen Stuart J, Dierikx C, Al Naiemi N et al. Rapid detection of TEM, SHV and CTX-m extended-spectrum β-lactamases in enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother 2010; 65: 1377-1381.
17. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-4558.
18. Clermont O, Dhanji H, Upton M et al. Rapid detection of the o25b-st131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 2009; 64: 274-277.
19. Ribot EM, Fair MA, Gautom R et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for Pulsenet. Foodborne Pathog Dis 2006; 3: 59-67.
20. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
21. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-272.
22. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-228.
23. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli o25b-st131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011; 66: 1-14.
24. Titelman E, Iversen A, Kahlmeter G, Giske CG. Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae. APMIS 2011; 119: 853-863.
25. Onnberg A, Molling P, Zimmermann J, Soderquist B. Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden. APMIS 2007; 119: 287-295.
26. Fang H, Ataker F, Hedin G, Dornbusch K. Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol 2008; 46: 707-712.
27. Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resist Updat 2000; 3: 303-311.
28. Struwe J, Olsson-Liljequist B. Short summary of Swedres 2008, a report on antimicrobial utilisation and resistance in humans in Sweden. Euro Surveill 2009; 14: pii. 19252.
29. Andersson H, Lindholm C, Iversen A et al. Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a Swedish municipality: healthcare staff knowledge of and adherence to principles of basic infection prevention. Scand J Infect Dis 2012; 44: 641-649.
30. Chabok A, Tarnberg M, Smedh K et al. Prevalence of fecal carriage of antibiotic-resistant bacteria in patients with acute surgical abdominal infections. Scand J Gastroenterol 2010; 45: 1203-1210.